NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

TECH

Bio-Techne Corp

May 23 • 04:00PM ET

46.78

Dollar change -0.54
Percentage change -1.14	%

Healthcare • Biotechnology • USA • NASD

Peers: TMO DHR ILMN A BIO QGEN NEO MTD

| Held by: VTI VOO VB VBK RSP SPY IVV XLV IBB IWR

Scroll to Statements

Index	S&P 500	P/E	57.02	EPS (ttm)	0.82	Insider Own	1.13%	Shs Outstand	156.76M	Perf Week	-4.82%
Market Cap	7.33B	Forward P/E	22.43	EPS next Y	2.09	Insider Trans	-0.85%	Shs Float	154.99M	Perf Month	-7.88%
Income	131.65M	PEG	5.57	EPS next Q	0.51	Inst Own	104.61%	Short Float	4.18%	Perf Quarter	-28.65%
Sales	1.21B	P/S	6.07	EPS this Y	7.64%	Inst Trans	2.26%	Short Ratio	2.98	Perf Half Y	-29.52%
Book/sh	12.87	P/B	3.63	EPS next Y	9.46%	ROA	4.91%	Short Interest	6.48M	Perf Year	-43.42%
Cash/sh	0.90	P/C	52.13	EPS next 5Y	10.24%	ROE	6.53%	52W Range	46.01 - 83.96	Perf YTD	-35.05%
Dividend Est.	0.26 (0.55%)	P/FCF	33.22	EPS past 5Y	11.13%	ROI	5.42%	52W High	-44.28%	Beta	1.39
Dividend TTM	0.32 (0.68%)	Quick Ratio	2.58	Sales past 5Y	10.61%	Gross Margin	66.52%	52W Low	1.67%	ATR (14)	2.34
Dividend Ex-Date	May 19, 2025	Current Ratio	3.71	EPS Y/Y TTM	-35.33%	Oper. Margin	22.40%	RSI (14)	39.97	Volatility	3.29% 3.32%
Employees	3100	Debt/Eq	0.21	Sales Y/Y TTM	4.72%	Profit Margin	10.89%	Recom	1.88	Target Price	66.70
Option/Short	Yes / Yes	LT Debt/Eq	0.20	EPS Q/Q	-53.50%	Payout	30.61%	Rel Volume	0.68	Prev Close	47.32
Sales Surprise	-0.32%	EPS Surprise	10.32%	Sales Q/Q	4.20%	Earnings	May 07 BMO	Avg Volume	2.18M	Price	46.78
SMA20	-5.26%	SMA50	-11.46%	SMA200	-30.67%	Trades		Volume	1,470,871	Change	-1.14%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-09-25	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Mar-18-25	Initiated	Evercore ISI	Outperform	$75
Feb-19-25	Downgrade	Robert W. Baird	Outperform → Neutral	$88 → $68
May-22-24	Downgrade	Citigroup	Buy → Neutral	$85
Feb-08-24	Initiated	Scotiabank	Sector Outperform	$80
Feb-02-24	Downgrade	Stifel	Buy → Hold	$65
Dec-07-23	Initiated	UBS	Buy	$80
Aug-28-23	Initiated	William Blair	Outperform
Jan-10-23	Upgrade	Wells Fargo	Underweight → Equal Weight	$90
Dec-14-22	Initiated	Deutsche Bank	Buy	$100
Dec-12-22	Upgrade	Citigroup	Neutral → Buy	$81.25 → $100
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$89
Aug-25-22	Initiated	Credit Suisse	Outperform	$465
Apr-25-22	Downgrade	Wells Fargo	Equal Weight → Underweight	$370
Sep-15-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$600
Mar-08-21	Upgrade	Stephens	Equal-Weight → Overweight	$380 → $425
Feb-23-21	Upgrade	Stifel	Hold → Buy	$435
Jan-25-21	Reiterated	The Benchmark Company	Buy	$320 → $410
Nov-10-20	Initiated	KeyBanc Capital Markets	Sector Weight	$340
Sep-30-20	Initiated	Atlantic Equities	Overweight	$365

Show Previous Ratings

May-14-25 04:54PM	S&P 500 Gains & Losses Today: Supermicro Stock Surges After DataVolt Deal (Investopedia) -7.27%
11:00AM	What Makes Bio-Techne Corporation (TECH) a Compelling Addition? (Insider Monkey)
07:00AM	ScaleReady awards multiple G-Rex Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA) (PR Newswire)
May-12-25 07:00AM	Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025 (PR Newswire) +7.93%
May-10-25 11:55AM	Biotech Alert: Searches spiking for these stocks today (TipRanks)
09:30AM	Loading…
May-08-25 09:30AM	Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing (PR Newswire)
07:00AM	Bio-Techne to Present at the BofA Securities 2025 Health Care Conference (PR Newswire)
03:16AM	Bio-Techne Corp (TECH) Q3 2025 Earnings Call Highlights: Strong Organic Growth Amid Global ... (GuruFocus.com)
01:44AM	Q3 2025 Bio-Techne Corp Earnings Call (Thomson Reuters StreetEvents)
May-07-25 04:09PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
10:40AM	Bio-Techne outlines 2025 growth drivers with NIH uncertainty and strong Protein Sciences performance (Seeking Alpha)
10:38AM	Bio-Techne Corporation (TECH) Q3 2025 Earnings Call Transcript (Seeking Alpha)
10:05AM	Bio-Techne Q3 Earnings & Revenues Top Estimates, Stock Up in Premarket (Zacks)
09:54AM	Bio Techne (TECH) Fell on Negative Funding Environment (Insider Monkey)
09:30AM	Techne (TECH) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
08:34AM	Loading…
08:34AM	Is the Options Market Predicting a Spike in BioTechne Stock? (Zacks)
07:40AM	Techne (TECH) Q3 Earnings and Revenues Beat Estimates (Zacks)
06:30AM	BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS (PR Newswire)
06:30AM	BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM (PR Newswire)
May-06-25 07:00AM	ScaleReady awards a $300,000 G-Rex Grant to A2 Biotherapeutics, Inc. (PR Newswire)
May-05-25 10:00AM	Earnings Preview: Arcturus Therapeutics (ARCT) Q1 Earnings Expected to Decline (Zacks)
May-02-25 07:54AM	Should You Hold Bio-Techne Corp. (TECH) For the Long Term? (Insider Monkey)
May-01-25 08:25AM	Alkermes (ALKS) Misses Q1 Earnings and Revenue Estimates (Zacks)
Apr-30-25 10:01AM	Techne (TECH) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
07:51AM	TECH Gears Up to Report Q3 Earnings: Here's What to Expect (Zacks)
Apr-29-25 07:00AM	ScaleReady Announces March Biosciences as Recipient of G-Rex Grant to Advance Manufacturing of Novel CAR-T Cell Therapy (PR Newswire)
Apr-24-25 09:45AM	Aristotle Focus Growth Q1 2025 Commentary (Seeking Alpha)
09:09AM	Bio-Techne Corporation (TECH) Slid Due to NIH's Funding Concerns (Insider Monkey)
07:00AM	Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection (PR Newswire)
Apr-23-25 07:00AM	Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting (PR Newswire)
08:00AM	Loading…
Apr-21-25 08:00AM	OmniAb Announces Two New Appointments to its Board of Directors (Business Wire)
Apr-15-25 07:00AM	Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results (PR Newswire)
Apr-14-25 02:09PM	Aristotle Large Cap Growth Q1 2025 Commentary (Seeking Alpha)
Apr-11-25 11:20AM	Novavax slides after RFK Jr. casts doubts about COVID vaccine (TipRanks)
Apr-10-25 01:32PM	Analyst Report: Bio-Techne Corporation (Morningstar Research) -8.90%
08:40AM	Strength Seen in Bio-Techne (TECH): Can Its 10.8% Jump Turn into More Strength? (Zacks)
Apr-09-25 09:46AM	Apple, Starbucks upgraded: Wall Street's top analyst calls (The Fly) +10.78%
Apr-08-25 06:49PM	Analyst Report: Bio-Techne Corporation (Morningstar Research) -6.69%
Apr-03-25 10:03AM	Dianthus Therapeutics, Inc. (DNTH) Soars 6.1%: Is Further Upside Left in the Stock? (Zacks) -6.03%
Apr-02-25 07:00AM	Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument (PR Newswire)
Mar-31-25 10:00AM	Bio-Techne Opens New Customer Experience Centre in Germany (Zacks)
05:12AM	3 Reasons to Avoid TECH and 1 Stock to Buy Instead (StockStory)
Mar-28-25 05:06AM	Research Tools & Consumables Stocks Q4 Earnings: Bio-Techne (NASDAQ:TECH) Best of the Bunch (StockStory)
Mar-26-25 11:10AM	Columbia Acorn Fund Q4 2024 Commentary (SeekingAlpha)
07:00AM	Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany (PR Newswire)
Mar-24-25 07:00AM	Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting (PR Newswire)
Mar-17-25 05:09AM	Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks (StockStory)
Mar-12-25 05:03AM	Q4 Earnings Highlights: Sotera Health Company (NASDAQ:SHC) Vs The Rest Of The Research Tools & Consumables Stocks (StockStory)
05:01AM	Research Tools & Consumables Stocks Q4 Recap: Benchmarking Bruker (NASDAQ:BRKR) (StockStory)
Mar-10-25 07:00AM	Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System (PR Newswire)
Mar-07-25 11:31AM	Techne (TECH) Down 15.5% Since Last Earnings Report: Can It Rebound? (Zacks)
Mar-05-25 04:02AM	Q4 Earnings Highlights: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks (StockStory)
Mar-04-25 04:02AM	Unpacking Q4 Earnings: Danaher (NYSE:DHR) In The Context Of Other Research Tools & Consumables Stocks (StockStory)
Mar-03-25 07:00AM	Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes (PR Newswire)
04:03AM	Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks (StockStory)
Feb-28-25 08:36AM	Weitz Partners III Opportunity Fund Added Bio-Techne Corporation (TECH) to its Portfolio (Insider Monkey)
Feb-27-25 07:00AM	Bio-Techne to Present at Investor Conferences (PR Newswire)
Feb-20-25 07:00AM	Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology (PR Newswire)
Feb-18-25 07:00AM	Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System (PR Newswire)
Feb-10-25 07:19PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Feb-06-25 02:09AM	Bio-Techne Corp (TECH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
12:40AM	Q2 2025 Bio-Techne Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-05-25 08:18PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
08:13AM	Illumina (ILMN) Reports Earnings Tomorrow: What To Expect (StockStory)
06:41AM	Bio-Techne (NASDAQ:TECH) Surprises With Strong Q4, Stock Soars (StockStory)
06:30AM	Bio-Techne Releases Second Quarter Fiscal 2025 Results (PR Newswire)
06:30AM	Bio-Techne Declares Dividend (PR Newswire)
Feb-04-25 07:00AM	Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors (PR Newswire)
Jan-21-25 07:00AM	ScaleReady Announces a G-Rex Grant has been awarded to BrainChild Bio (PR Newswire)
07:00AM	Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results (PR Newswire)
Jan-10-25 07:00AM	Bio-Techne Expands RandD Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine (PR Newswire)
07:00AM	Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine (PR Newswire)
Jan-08-25 07:00AM	ScaleReady Announces a G-Rex Grant has been awarded to Seattle Children's Therapeutics (PR Newswire)
07:00AM	BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025 (PR Newswire)
Jan-07-25 07:00AM	BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC (PR Newswire)
Dec-20-24 07:00AM	BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE (PR Newswire)
Dec-19-24 07:00AM	BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT (PR Newswire)
Dec-18-24 07:00AM	ScaleReady awards a G-Rex Grant to Moonlight Bio (PR Newswire) -5.13%
Dec-12-24 07:00AM	BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY (PR Newswire)
Dec-10-24 07:00AM	BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY (PR Newswire)
Dec-09-24 07:33PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Nov-29-24 11:32AM	Techne (TECH) Up 2.2% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-27-24 07:00AM	BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
Nov-25-24 09:02AM	Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne (PR Newswire)
Nov-22-24 09:00AM	OverT Bio Receives $120K G-Rex Grant to Propel Solid Tumor Cell Therapy Advancements (Business Wire)
Nov-20-24 07:00AM	BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES (PR Newswire)
Nov-18-24 07:00AM	BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH (PR Newswire)
Nov-15-24 06:58PM	Analyst Report: Bio-Techne Corporation (Morningstar Research) -6.85%
Nov-14-24 07:00AM	BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO (PR Newswire)
Nov-11-24 05:47PM	UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS (PR Newswire)
07:00AM	BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS (PR Newswire)
Nov-08-24 07:00AM	BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES (PR Newswire)
Nov-07-24 07:00AM	ScaleReady Announces multiple G-Rex Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy (PR Newswire)
Nov-06-24 07:00AM	BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING (PR Newswire)
12:05AM	Beyond the Balance Sheet: What SWOT Reveals About Bio-Techne Corp (TECH) (GuruFocus.com)
Nov-05-24 06:51PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
07:00AM	LUNAPHORE COMET PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH (PR Newswire)
Oct-31-24 10:39AM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
03:08AM	Bio-Techne Corp (TECH) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges in a ... (GuruFocus.com)
01:01AM	Q1 2025 Bio-Techne Corp Earnings Call (Thomson Reuters StreetEvents)

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Genomics segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Genomics segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
HIGGINS JOHN L	Director	May 01 '25	Option Exercise	21.84	12,000	262,080	60,196	May 05 04:18 PM
Bohnen Shane	SVP - General Counsel	Apr 03 '25	Option Exercise	0.00	2,260	0	3,941	Apr 07 04:25 PM
Herr Amy E.	Director	Feb 14 '25	Option Exercise	44.33	1,976	87,596	3,836	Feb 18 04:49 PM
Herr Amy E.	Director	Feb 14 '25	Sale	65.96	1,860	122,691	1,976	Feb 18 04:49 PM
JOSHUA MOLHO	Domestic Partner of Director	Feb 14 '25	Proposed Sale	65.96	1,860	122,691		Feb 14 04:08 PM
McManus Matthew	President - DGS	Feb 01 '25	Option Exercise	0.00	4,620	0	4,620	Feb 04 05:31 PM
Geist William	PRESIDENT, PROTEIN SCIENCES	Feb 01 '25	Option Exercise	0.00	3,320	0	14,401	Feb 04 05:27 PM
Kelderman Kim	Chief Executive Officer	Jan 27 '25	Option Exercise	37.70	13,392	504,878	52,396	Jan 29 04:35 PM
Kelderman Kim	Chief Executive Officer	Jan 27 '25	Sale	77.29	13,392	1,035,013	39,004	Jan 29 04:35 PM
KIM KELDERMAN	Director	Jan 27 '25	Proposed Sale	77.05	13,392	1,031,854		Jan 27 04:24 PM
Geist William	PRESIDENT, PROTEIN SCIENCES	Nov 01 '24	Option Exercise	0.00	9,912	0	14,351	Nov 05 04:48 PM
Hippel James	CFO	Nov 01 '24	Option Exercise	0.00	13,159	0	113,085	Nov 05 04:46 PM
HIGGINS JOHN L	Director	Sep 12 '24	Option Exercise	22.95	6,000	137,700	48,608	Sep 16 04:18 PM
Kelderman Kim	Chief Executive Officer	Aug 29 '24	Option Exercise	66.97	1,492	99,919	41,434	Sep 03 04:05 PM
Bohnen Shane	SVP - General Counsel	Aug 15 '24	Option Exercise	0.00	49	0	1,696	Aug 19 05:28 PM
BAUMGARTNER ROBERT V	Director	Aug 08 '24	Option Exercise	22.95	16,000	367,200	59,401	Aug 12 04:08 PM
BAUMGARTNER ROBERT V	Director	Aug 08 '24	Sale	72.10	16,000	1,153,664	43,401	Aug 12 04:08 PM
ROBERT V. BAUMGARTNER	Director	Aug 08 '24	Proposed Sale	72.10	16,000	1,153,664		Aug 08 04:13 PM
Hippel James	CFO	Aug 02 '24	Option Exercise	31.26	53,000	1,656,780	136,002	Aug 06 04:23 PM
Kelderman Kim	Chief Executive Officer	Jul 31 '24	Option Exercise	37.70	14,000	527,800	49,421	Aug 02 04:17 PM
Hippel James	CFO	Jul 23 '24	Option Exercise	31.26	35,000	1,094,100	107,284	Jul 25 04:31 PM
HIGGINS JOHN L	Director	Jul 08 '24	Option Exercise	22.95	6,000	137,700	42,608	Jul 10 04:35 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TECH

Bio-Techne Corp

Upgrade your FINVIZ experience